Regulation of glycosaminoglycan structure and atherogenesis.
about
Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for ProteoglycansAtherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscleGenome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life.Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathwaysLOX-1 in atherosclerosis: biological functions and pharmacological modifiers.Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis.Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis.Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor transactivation in vascular smooth muscle cells.The endothelial glycocalyx: composition, functions, and visualization.Heparan Sulfate Regrowth Profiles Under Laminar Shear Flow Following Enzymatic Degradation.Biosynthesis of natural and hyperelongated chondroitin sulfate glycosaminoglycans: new insights into an elusive process.Multiple Growth Factors, But Not VEGF, Stimulate Glycosaminoglycan Hyperelongation in Retinal Choroidal Endothelial Cells.Nanomechanics of vascular endothelium.Differential proteoglycan and hyaluronan distribution in calcified aortic valvesGrowth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation.Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells.(S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
P2860
Q26738776-B1AB739E-387C-4813-957A-7CE14BEACC11Q33593675-B37915FF-4C3C-4667-8C1F-E2D0F153665CQ33743013-58CD58E5-3604-47D7-BD53-9F7A233C5B57Q33747946-789B5504-C11C-49CC-AAE1-7F29E4274F37Q34079451-99E64400-5BAB-4BD3-9144-FD767E3F7F82Q34094307-7D361ECD-6D87-4EA3-A3BA-9CB139D7D075Q34548738-6E47FB17-8055-4451-87FA-8D5563CAD67AQ36012843-CE892043-4ACB-4BE3-8B77-F40A8240A5C1Q36013136-9EAEE046-2735-48BE-8BFD-19877CCBF05DQ36666309-3EEF86B6-B3A8-47B1-A540-62BAE7AC32F8Q36719459-BFC8D231-F41E-468E-9CF1-E5422D4E6BE6Q36947609-1B967061-F057-452A-9302-B10AD4312890Q37063922-0A100976-22C7-4345-9008-3E44179C3AFBQ37201972-B3F3C430-D764-4C40-8F3B-FB7684545D2AQ38197106-628685DC-CC5D-453E-85FA-4118CBB5CE75Q42084953-AD7CF43D-E321-426C-815A-0EE933D0BCEEQ45938367-B1D48FC3-33B0-429A-8ECB-0054BA8EC758Q46203810-2FC703ED-B98A-4F6D-B195-6C6AFD89C7BCQ50935191-0D12B792-E5F0-458D-8D7B-463C04B73156
P2860
Regulation of glycosaminoglycan structure and atherogenesis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Regulation of glycosaminoglycan structure and atherogenesis.
@ast
Regulation of glycosaminoglycan structure and atherogenesis.
@en
type
label
Regulation of glycosaminoglycan structure and atherogenesis.
@ast
Regulation of glycosaminoglycan structure and atherogenesis.
@en
prefLabel
Regulation of glycosaminoglycan structure and atherogenesis.
@ast
Regulation of glycosaminoglycan structure and atherogenesis.
@en
P2093
P1476
Regulation of glycosaminoglycan structure and atherogenesis.
@en
P2093
Ballinger ML
Frontanilla KV
P2888
P304
P356
10.1007/S00018-004-3389-4
P577
2004-06-01T00:00:00Z